Medical Marijuana Market Report

Medical Marijuana Market Report

Medical Marijuana Market Report
Report code - SRHL249 Delivery - 2 Weeks
Global Medical Marijuana Market, Dynamics, Market Analysis
See more...

Market Insights

The Global Medical Marijuana Market is estimated to grow from USD 21.1 billion in 2020 to USD 53.0 billion by 2026 at a healthy CAGR of 17% during the forecast period.

Figure: Global Medical Marijuana Market Size, 2020-2026 (USD Billion)

Medical-Marijuana-Market-Forecast

Wish to get a free sample report? Click here.

What is Medical marijuana?

Medical marijuana is also known as medical cannabis is a herbal drug derived from plants of cannabis. This is used as a part of the treatment for specific diseases. Medical marijuana is particularly classified as cannabis Indica and cannabis Sativa, which originate from the countries of central & south Asian region and the western hemisphere respectively.

Key Players

Key players operating in the global Medical Marijuana market are-

  • Tilray (The U.S),
  • Canopy Growth Corporation (Canada),
  • Aurora Cannabis Inc. (Canada),
  • Maricann Group Inc. (Canada),
  • Aphria Inc. (Canada),
  • Tikun Olam (Israel),
  • GW Pharmaceuticals (UK),
  • Cannabis Sativa (The U.S),
  • Medical Marijuana, Inc. (The U.S), and
  • MedReleaf Corp. (The U.S).

Market Dynamics

The global market growth is primarily driven by the increasing usage of medical marijuana in various medical applications including mental disorders, arthritis, chronic pain, and cancer among others.

  • The continuous investment in research and development activities to provide intervention for various diseases and symptoms is likely to boost the product demand at a significant rate.
  • The increase in several countries legalizing the use of marijuana for medical and recreational purposes is likely to create lucrative opportunities for the market players.

Segment Analysis

Application Trends

Based on application, the market has been divided into chronic pain, mental disorders, cancer, and others.

  • The chronic pain segment accounted for the largest share in 2020 on account of increasing number of clinical trials using marijuana to treat chronic pain.
  • The cancer segment is projected to grow at the fastest CAGR during the review period.

Regional Trends

The market in North America accounted for the largest market share of around 45% in 2020 due to presence of key market players such as Medical Marijuana, Inc. (US), Canopy Growth Corporation (Canada) and Aurora Cannabis Inc. (Canada).

Additionally, an increasing number of states legalizing the use of marijuana for medical purposes in the US is likely to play a significant role in the regional market growth.  The market in the Asia-Pacific region is projected to register a healthy growth rate on account of rising awareness regarding product benefits, particularly in China and India.

COVID-19 Impact on Global Medical Marijuana market

The sales of cannabis products increased at a significant rate in the early weeks of the coronavirus pandemic. The sale of medical marijuana surged to new heights after the state and local authorities in the United States deemed medical marijuana as an essential business. Also, the number of new customers consuming marijuana increased substantially during the outbreak in countries or states where the consumption of medical marijuana was legalized.

Critical Questions Answered in the report -

  • What are the key trends in the global medical marijuana market?
  • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
  • What is the impact of COVID-19 on the global medical marijuana market?
  • What are the key strategies adopted by the major vendors to lead in the global medical marijuana market?
  • What is the market share of the top vendors?

Register here to get your customized report.

Target Audience

Here is the list of the group of customers that the Medical Marijuana market hopes to have the greatest opportunity to convert-

  • Medical marijuana distributors
  • Medical marijuana suppliers
  • Medical marijuana manufacturers
  • Logistics organizations
  • Government Bodies

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

The medical marijuana market is expected to witness an impressive growth of 17% CAGR in the coming years.

Tilray (The U.S), Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Maricann Group Inc. (Canada), Aphria Inc. (Canada), Tikun Olam (Israel), GW Pharmaceuticals (UK), Cannabis Sativa (The U.S), Medical Marijuana, Inc. (The U.S) and MedReleaf Corp. (The U.S) are among the key players in the medical marijuana market.

The medical marijuana market size is expected to reach USD 53.0 billion in the foreseeable future.

North America accounted for the largest share of the medical marijuana market in 2020.

The cancer segment is expected to grow at the fastest CAGR in the medical marijuana market in the coming five years.

Increasing usage of medical marijuana in various medical applications including mental disorders, arthritis, chronic pain, and cancer among others, continuous investment in research and development activities to provide intervention for various diseases and symptoms are the factors driving the growth of medical marijuana market.

Medical marijuana distributors, Medical marijuana suppliers, Medical marijuana manufacturers, Logistics organizations, Government Bodies are the target audience in the medical marijuana market.